ONCOL REP 润色咨询

ONCOLOGY REPORTS

出版年份:1994 年文章数:5979 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2023-06-13 ms00020231314666

    投稿命中率:50.0
    经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2023-02-04 woshiliwj 来自浙江省

    麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2022-08-14 ms8000001803522035

    6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2023-07-06 ms5000000683483699 来自山东省

    偏重的研究方向:肿瘤
    经验分享:请问编辑under review一般持续多久呀

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2022-06-11 ms8000001803522035

    发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2019-08-28 1085404196_71099776

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2023-01-31 woshiliwj 来自浙江省

    这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2022-03-16 蜗牛蜗牛2

    审稿速度:1.0
    偏重的研究方向:肿瘤
    经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2022-01-25 ms6000001428377527

    请问接受生信分析杂志吗?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0<br>经验分享:这个杂志的Under review 和Under Review有区别吗,是不是前者是编辑在审后者是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下,投了international journal of oncology ,一个多月修回,评审专家意见还可以,但是建议转投oncology reports ,修改后再次投稿,第二天编辑就回复,针对评审专家问题再提了问题,还要了伦理及知情同意,请问这样是不是希望比较大?还会再发给评审专家吗,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿,8月12日发邮件暂时接收,后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向:肿瘤<br>经验分享:请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式,还需要300dpi,单栏8CM,啥意思,是需要我最后以word形式重新投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单,2021剔除了预警,今天2023.1.31最新,又被剔除出预警名单,这个杂志应该可以放心投稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1203058, encodeId=4574120305897, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:杂志编辑审稿速度特别快,3.13提交,3.15给出意见建议修改后重新提交。还没有送外审。希望可以早日命中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ULSZxjHNT5bgv1d4K4khOaKn15INW9NZdGuiaZBa6FktWicqzTljbPo3moNXQ2ty1qHuw23JsDCSlbTAl7ROoxkA/132, createdBy=facc2384501, createdName=蜗牛蜗牛2, createdTime=Wed Mar 16 11:43:09 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188154, encodeId=5d3f1188154b1, content=请问接受生信分析杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=30bd5494379, createdName=ms6000001428377527, createdTime=Tue Jan 25 22:43:15 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-08-28 ms9405311671463132

    我的文章7.13号under review,现在已经8.29了,突然看见action位置提示replace files,邮箱里找了个遍也没看到通知修改的邮件,大家有知道是什么状况的吗?我都有些毛了,我找了垃圾箱也没有啊

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分